Whether insulin-mediated vasodilation is important in determining insulin's overall action to stimulate glucose uptake is unknown. To this end, we measured leg glucose uptake during euglycemic hyperinsulinemic clamps performed at two insulin doses (40 mU/m2 per min, n = 6 and 120 mU/M2 per min, n = 15) alone and during a superimposed intrafemoral artery infusion of GN-monomethyl-L-arginine (L-NMMA) designed to blunt insulin-mediated vasodilation. During the higher dose study, hyperinsulinema resulted in about a twofold rise in basal leg blood flow from 0.24±0.02 to 0.45±0.05 liter/min, P < 0.0001. L-NMMA infusion resulted in a net 21% reduction in leg glucose uptake from 114+±18 mg/min to 85+±13 mg/min, P < 0.001. We also found a significant relationship between the rate of insulin-stimulated whole body glucose uptake and the magnitude of flow dependent glucose uptake (r = 0.57, P = 0.02). Data obtained during the lower dose insulin infusion resulted in similar findings. In conclusion, in healthy lean subjects, insulin-stimulated muscle blood flow contributes to both insulin responsiveness and insulin sensitivity. The most insulin-sensitive subjects appear to be the most reliant on muscle perfusion for insulin action. Insulin-mediated vasodilation is an important physiological determinant of insulin action. (J.
Introduction
Physiological insulin concentrations cause an approximate twofold increase in resting skeletal muscle blood flow in insulinsensitive but not insulin-resistant humans ( 1, 2) . We have previously reported that insulin's effect to increase skeletal muscle perfusion is highly correlated with its ability to stimulate glucose uptake, suggesting a tight coupling between perfusion and insulin sensitivity (1) . However, this association could only suggest but not prove a causal effect of perfusion to act as a determinant of glucose uptake.
Systemic administration of angiotensin 11(3) enhances insulin-mediated glucose uptake which appears to be the result of increased muscle perfusion. We have recently reported that acute increments in skeletal muscle perfusion with intraarterial methacholine which releases endothelium derived nitric oxide can markedly augment insulin stimulated leg (muscle) glucose uptake (4) . These data strongly support an independent role for enhancement of muscle perfusion to modulate in vivo glucose uptake. Nevertheless, definitive evidence for the ability of insulin-mediated increments in skeletal muscle blood flow to play a role in insulin sensitivity and for reduction of perfusion to cause insulin resistance is currently lacking. At first glance it might appear obvious that if perfusion enhancement augments glucose uptake, its reduction should lead to insulin resistance. However, reduction in blood flow (F) is accompanied by increments in muscle glucose extraction (reflected by arteriovenous glucose difference, AVGA' which can potentially offset any change in perfusion and result in no net change in glucose uptake (GU), GU = AVGL X F (5).
This occurs because the reduction in perfusion leads to an increase in the transit or residence time of glucose along the length of the capillary leading to greater glucose exchange. Thus, it remains to be proven and important to establish whether insulin-mediated augmentation of skeletal muscle perfusion is instrumental in determining insulin action.
We have recently reported that insulin-mediated vasodilation (perfusion) is endothelium-derived nitric oxide dependent (6) since it can be abrogated by the infusion of the specific inhibitor of nitric oxide synthase, 'N-monomethyl-L-arginine (L-NMMA). Thus, a pharmacologic "tool" is now available to specifically reduce insulin induced vasodilation. The purpose of this study was to directly examine the role of insulin-mediated increments in skeletal muscle perfusion on insulin's action to stimulate glucose uptake. To this end, we combined the euglycemic hyperinsulinemic clamp and the leg balance technique to measure steady state rates of leg muscle glucose uptake at rest, during high physiological hyperinsulinemia and during a superimposed intrafemoral artery infusion of L-NMMA designed to blunt the insulin induced rise in muscle perfusion in a group of healthy volunteers.
Methods
Subjects. The characteristics of the study groups are shown in Table I . 21 subjects were selected to have a body mass index of < 27 with no family or personal history of diabetes or hypertension. All subjects were healthy and not ingesting any medications at the time of study. All were admitted to the Indiana University Clinical Research Center 2 d before the study and fed an isocaloric diet the caloric composition of which 1. Abbreviations used in this paper: AV, arteriovenous; AVGA, AV glucose difference; LBF, leg blood flow; LGU, leg glucose uptake; L-NMMA, -Nmonomethyl-L-arginine. Compared to the six subjects in group I who all exhibited a percent body fat < 22%, group H (studied the higher insulin dose) exhibited a wide range of body fat content (up to 38%). Therefore, to better compare the effect of different insulin concentrations on the metabolic and hemodynamic parameters, we compared a subgroup of subjects from group H (n = 10, group III) that were matched for body composition to group I (see Table I ).
Analytical methods. Blood for serum glucose determinations was drawn, put in untreated polypropylene tubes, and centrifuged with an Eppendorf microcentrifuge (Brinkmann Instruments, Inc., Westbury, NY). The glucose and lactate concentrations of the supernatant were measured by the oxidase method with a glucose/lactate dual channel analyzer (model 2300 Stat; Yellow Springs Instrument Co., Yellow Springs, OH). Blood for determination of plasma insulin concentrations was collected in tubes treated with heparin. The specimens were spun, and the supernatant was removed and stored at -20°C. Plasma insulin levels were measured by double-antibody radioimmunoassay (Coatacount; Diagnostic Products Corp., Los Angeles, CA). Blood for determination of plasma glucose-specific activity was collected in sodium fluoride-treated tubes and immediately placed on ice. The specimens were spun, and the supernatant was removed and stored at -20°C. At the time of assay the serum was thawed and diluted, and the proteins were precipitated with 0.6 M perchloric acid. The supernatant was divided equally, evaporated to dryness, resuspended in 0.5 ml distilled water to which 10 ml of liquid scintillation counting fluid was added (National Diagnostics, Atlanta, GA), and counted for 5 min.
Statistical analysis. Data are shown as the means±SE. Comparison were made using analysis of variance. Paired comparisons were performed with the one-tailed Student's t test. Significance was considered at the P < 0.05 level. All statistics were performed on a Macintosh computer with Statview IV (Abacus Concepts, Berkeley, CA).
Results
Glucose, lactate and insulin concentrations (Table II) The mean fasting serum glucose concentration and steady state serum glucose concentration during euglycemic hyperinsulinemia (40 and 120 mU/m2 per min) with and without concomitant infusion of L-NMMA were not significantly different. Basal insulin concentrations were not different between groups. The steady state serum insulin concentration were 69±3 and 210±13 1iU/ml during euglycemic hyperinsulinemia during the 40 and M M2 120 mU/in per min insulin infusions, respectively. During superimposed L-NMMA infusion steady state serum insulin concentrations tended on average to be higher than during insulin (Table III) . With superimposed intraarterial L-NMMA, the AVGA increased within 5 min of the onset of the infusion and reached a new steady state after 15 min of L-NMMA infusion (Table III (Fig. 2) .
Basal serum lactate AV difference was 0.087±0.09, -0.091±0.019, and -0.094±0.027 mmol/liter and increased to -0.279±0.018, -0.288±0.018, and -0.298±0.023 mmol/ liter during hyperinsulinemia in groups I, II, and II, respectively, P < 0.05 vs baseline but P = NS between groups. During intraarterial L-NMMA infusion the AV difference for lactate was unchanged, -0.272±0.034, -0.266±0.019, and -0.259±0.022 mmol/liter in groups I, II, and HI, respectively, P = NS vs insulin alone, and P = NS between groups (Table II) .
Leg blood flow. Fig. 2 ).
Rates of LGU and lactate balance. Hyperinsulinemia resulted in a marked rise in rates of LGU from a basal rate of 5.0 mg/min to 107.1±16.9, 114.2±18.2, and 140.4±22.9 mg/min, in groups I, II, and III P < 0.0001 (Fig. 3) (Fig. 3) .
Hyperinsulinemia resulted in a marked rise in negative lactate balance (net lactate release) from a basal rate of -0.004±0.002, -0.015±0.004, and -0.023±0.008 to -0.101±0.019, -0.094±0.015, and -0.143±0.022 mmol/min, P < 0.0001 vs insulin alone in groups I, II, and III, respectively.
With superimposed L-NMMA infusion steady state lactate balance (15-30 min of L-NMMA infusion) decreased by 60.8±4.9% to -0.035±0.008 mmol/min in group I, P < 0.02, by 60.8±4.9% to -0.035±0.008 mmol/min in group HI, P < 0.002, and by 59.3±5.3% to -0.055±0.013 mmol/min in group III, P < 0.002.
As gauged by lactate equivalents of glucose (2 mol of lactate/mol of glucose) the proportion of LGU which was released as lactate was reduced by -40% at both insulin concentrations by the L-NMMA-induced reduction of perfusion.
Correlation and other analyses. As previously reported (1) we found a significant direct relationship between the rate of leg blood flow and the rate of whole body glucose uptake during insulin stimulation, r = 0.58, P < 0.01 (Fig. 4) . To explore the relationship between insulin sensitivity and the magnitude of perfusion-dependent muscle glucose uptake we examined whether a correlation exists between insulin responsiveness (rate of whole body insulin-mediated glucose uptake observed at the higher insulin dose) and the relative decrease in LGU induced by L-NMMA infusion. We found a significant inverse Subjects in Group I and II were studied at an insulin infusion rate of 40-120 mU/r2 per min, respectively. * P < 0.0001 vs baseline; * P < 0.001 vs insulin alone; I P < 0.0001 vs insulin alone; 11 P < 0.001 vs baseline; and 1P < 0.05 vs insulin alone. @ subjects not included in group I based on percent body fat >24.4. relationship between the degree of insulin responsiveness (insulin-mediated whole body glucose uptake) and the proportion of flow dependent glucose uptake, r = 0.57, P = 0.02, respectively (Fig. 5) . Thus, those subjects who were most insulin responsive tended to have both the greatest flow increments and conversely the greatest degree of flow dependent glucose uptake. (1) . These data suggested but did not provide proof that these two physiological events were causally related. The current study is the first time demonstration that insulin-mediated vasodilation plays a significant role in the determination of both insulin sensitivity and responsiveness as measured during a euglycemic hyperinsulinemic clamp in lean subjects.
In the current study we elected to first stimulate skeletal muscle blood flow and glucose uptake with steady state insulin concentrations in the physiologic (-75 AU/ml) and high but subpharmacologic range (-200 AU/ml). This resulted in an approximate twofold increase in leg blood flow above baseline at both insulin concentrations consistent with our previous reports (1, 2, 9) . After reaching steady state rates of glucose uptake and leg blood flow, we performed an intrafemoral artery infusion of L-NMMA designed to abolish the insulin-mediated rise in leg blood flow. With this maneuver we were able to completely reverse the insulin-mediated vasodilation and thus, reestablish basal rates of leg blood flow as we have recently reported (6) . Therefore, we established an experimental condition where insulin action was fully expressed but where the normal rise in skeletal muscle perfusion was restrained and leg blood flow was maintained at basal rates for sufficient time to establish steady state conditions. Despite a 50% increase in the AVGA, we observed an average -20-30% reduction in rates of LGU in body composition-matched subjects studied at both the lower and higher insulin infusion rates (Fig. 3) . Moreover, it is noteworthy that while subjects studied at the lower insulin dose (group I) displayed rates of whole body glucose uptake that were 33% lower than their lean counterparts studied at the higher insulin dose (group III), the femoral AVGA was similar in the two groups. Given that the rate of leg blood flow was higher in group III than in group I, one also can infer that the rate of muscle perfusion is an important determinant of the overall rate of glucose uptake. Thus, one can conclude that in healthy lean men, -20-30% of the overall rate of insulin-mediated glucose uptake is dependent on incre- Whole Body Glucose Uptake (mg/kg per mln) Figure 4 . Correlation between insulin mediated glucose disposal (GDR) and rates of leg blood flow during steady state euglycemic hyperinsulinemia in subjects studied at an insulin infusion rate of 120 mU/M2 per min (group II, n = 15) and 40 mU/M2 per min (group I, n = 6).
ments in muscle perfusion at both submaximally effective (insulin sensitivity), and near maximally effective insulin concentrations (insulin responsiveness).
Closer inspection of the data reveals wide individual variation in the degree of perfusion-dependent LGU. In this regard, it is important to keep in mind that the rate of leg blood flow is directly related to the rate of glucose uptake (Fig. 4) . Therefore, if the rise in muscle perfusion is a determinant of the rate of insulin-stimulated glucose uptake one would expect that those individuals who exhibit the greatest insulin responsiveness (and (10) predict that individuals who exhibit the greatest degree of tissue permeability to glucose would be expected to display the greatest amount of flow-dependent uptake. Compared to lean insulin sensitive subjects, obese and NIDDM patients exhibit smaller AVGAs during insulin stimulation despite the fact that in these subjects muscle perfusion is modest which would tend to increase the AVGA ( 1, 2, 11 ). This suggests that glucose permeability is very poor and thus, one would not expect that an augmentation of muscle perfusion would have much modulating effect on glucose uptake in these subjects. Weight reduction and glycemic control greatly ameliorate (but do not normalize) insulin action in obese subjects by virtue of an increase in glucose extraction ( 12) . The persistent impairment in the hemodynamic response to insulin, however, could potentially contribute to the inability to normalize glucose uptake in these subjects. Clearly, more direct experimental data are required to determine the actual contribution of impaired tissue perfusion to insulin action in insulin resistant subjects.
We have previously proposed (13) The current data may have an important impact upon our current understanding of insulin resistance. It is possible, for example, that certain forms of insulin resistance are either entirely or in part secondary to defective insulin-mediated vasodilation. We have previously proposed that the insulin resistance associated with essential hypertension could be accounted for by a failure of insulin-mediated vasodilation (14) and recent data from our laboratory support this idea. We have reported that acute systemic infusion of L-NMMA in rats which results in both elevated blood pressure and decreased skeletal muscle perfusion (15) is associated with a marked reduction in rates of insulin-mediated glucose uptake (16) . Moreover, we have recently reported that in humans insulin-mediated vasodilation is inversely related to the height of the resting blood pressure ( 14) .
Finally, the results of our study are in part based upon the assumption that L-NMMA has no effect to reduce cellular glucose permeability per se. We have recently tested this idea by examining the effect of L-NMMA upon insulin stimulation of
[ 4C ]glucose incorporation into glycogen in isolated rat soleus muscle (16) . The data indicate that L-NMMA does not appear to have any effects on overall cellular membrane glucose transport and glycogen formation. While the effects of L-NMMA on insulin action are likely to be secondary to its hemodynamic action, one cannot completely rule out a direct effect of L-NMMA on cellular glucose uptake in vivo.
In conclusion, the current data support the notion that in lean individuals, insulin's action to increase skeletal muscle perfusion can account for as much as one-third of insulin's overall effect to stimulate glucose uptake. Therefore, it follows logically that a defect in this hemodynamic action could result in insulin resistance. Thus, the cardiovascular actions of insulin appear to be an integral part of insulin's overall effect to increase glucose disposal. Finally, it is possible that insulin substrates other than glucose (amino acids and lipids) are similarly modulated.
